Video
How to prevent Type 2 diabetes after gestational diabetes (16 proven strategies)Gestational diabetes and weight gain -
However, the rate of delivery of SGA infants was not significantly higher among those who either lost or maintained weight during GDM management than among those with cEGWG 7. However, it would be prudent to promote consumption of a healthy, balanced diet that meets the nutritional requirements of pregnancy in conjunction with providing any gestational weight gain advice and support.
This study has a number of strengths. To our knowledge, it is the first analysis to investigate the impact of early EGWG before GDM diagnosis and of cEGWG during GDM treatment, which involved the same diagnostic criteria and treatment targets through the data collection period.
Second, this single-center study had the same leading clinician J. and used the same standardized protocols throughout the data collection period, thereby minimizing clinical variation.
Finally, the sample size is large. This study also has a number of limitations. The findings may not be generalizable to all women with GDM, as this is a cohort of women with various ethnic backgrounds, significant socioeconomic disadvantage, and a high rate of GDM.
However, given that GDM is now prevalent worldwide, the range of high-risk ethnic groups represented in this study may make these findings more transferable to a significant proportion of high-risk ethnic groups. Further, the four main ethnic groups represented in our population were entered into the logistic regression model in order to determine independent predictors of insulin therapy.
None of the ethnicities confounded the associations found between cEGWG and the likelihood of requiring insulin therapy. Another limitation is the lack of neonatal intensive care data. In addition, the retrospective, observational study design carries several limitations including being unable to attribute causality.
Although maternal weight gain was associated with greater insulin requirements, the former may not be causal, particularly given the weight gain—inducing properties of insulin therapy. Also, the possibility of residual confounding cannot be completely excluded and could have influenced the associations we observed.
However, the sample size is large, and a number of confounders including maternal age, gestational age at GDM diagnosis, FPG on the g oGTT, ethnicity, and HbA 1c at presentation to the Diabetes Centre were taken into account in the analysis.
In conclusion, a positive clinical message can be taken from our findings. Further, the strengths of the associations observed here suggest a need to provide stronger support for women to achieve healthy maternal weight gain 6 both before and during GDM management, as doing so may have multiple potential benefits.
Reducing EGWG may reduce the risk of GDM by lowering the FPG value on a g oGTT and may decrease insulin requirements and adverse pregnancy outcomes in women with GDM.
Reducing both EGWG and cEGWG could reduce rates of delivering LGA infants and the associated complications, as well as related health care expenses.
Further, given that commencing and titrating insulin are both costly in terms of time and resources, there is also the potential to conserve clinical time and health care expenditure with lower insulin requirements. Weight management during GDM treatment could also reduce postpartum BMI—a significant benefit in these women, who are at high risk of GDM recurrence 39 and type 2 diabetes All these potential benefits need to be more definitively investigated in well-designed and adequately powered randomized controlled trials.
The authors also thank Professor Jason Gardosi, Director of the West Midlands Perinatal Institute, Birmingham, U. Duality of Interest.
No potential conflicts of interest relevant to this article were reported. Author Contributions. conceived and designed the study, performed background research, interpreted the data, and wrote and edited the manuscript.
conceived and designed the study, analyzed and interpreted data, provided statistical expertise, and critically revised the manuscript. interpreted the data, provided administrative and technical support, and critically revised the manuscript. acquired data, provided administration, and critically reviewed the manuscript.
interpreted data and critically revised the manuscript. interpreted data, critically revised the manuscript, and provided administrative and technical support.
interpreted the data and critically revised the manuscript. conceived and designed the study; acquired, analyzed, and interpreted data; provided administrative, technical, and material support; supervised; and critically revised the manuscript. approved the final version of the manuscript.
and J. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Prior Presentation. This study was presented at the Australasian Diabetes in Pregnancy Society Annual Scientific Meeting, Canberra, New South Wales, Australia, 20—22 October ; and at the 9th International Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy DIP , Barcelona, Spain, 8—12 March Sign In or Create an Account.
Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care.
Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 43, Issue 1.
Previous Article Next Article. Research Design and Methods. Article Information. Article Navigation. Excessive Weight Gain Before and During Gestational Diabetes Mellitus Management: What Is the Impact? Barnes Corresponding author: Robyn A.
Barnes, robyn. barnes2 health. This Site. Google Scholar. Tang Wong ; Tang Wong. Glynis P. Ross ; Glynis P. Michelle M. Griffiths ; Michelle M. Carmel E. Smart Clare E. Collins ; Clare E.
Lesley MacDonald-Wicks ; Lesley MacDonald-Wicks. Jeff R. Flack Jeff R. Diabetes Care ;43 1 — Article history Received:. Get Permissions. toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest.
Patient characteristics. Age years View Large. Figure 1. View large Download slide. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
A multicenter, randomized trial of treatment for mild gestational diabetes. Search ADS. Australian Carbohydrate Intolerance Study in Pregnant Women ACHOIS Trial Group. To speak to someone directly, please call If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.
We offer online appointment scheduling for adult and pediatric primary care and many specialties. UChicago Medicine and Ingalls Memorial offer a broad range of challenging clinical and non-clinical career opportunities doing work that really matters.
Skip to content Appointments Close Appointments Schedule your appointment online for primary care and many specialties. Schedule an Appointment Online To request an appointment, please use our secure online form. Request an Appointment Get an online second opinion from one of our experts without having to leave your home.
Get a Second Opinion Contact Us Contact Form and Phone Numbers. Close Patient Portal MyChart UChicago Medicine For help with MyChart, call us at Online Bill Pay Ingalls Memorial Bill Pay UChicago Medicine Bill Pay.
Forefront Women's Health. November 23, Written By Maritza Gonalez, MD, and Laura Dickens, MD Topics Diabetes in Pregnancy Maritza Gonzalez MD Diabetes Laura Dickens MD Maternal-Fetal Medicine High-Risk Pregnancy Care Endocrinology Women's Health Care Patient Care.
Call Us At What are the warning signs of gestational diabetes? What causes gestational diabetes? Can eating too much sugar cause gestational diabetes? Can gestational diabetes be prevented? Eating a balanced diet, including vegetables, fruits, whole grains, seafood and lean meats.
How can I get rid of gestational diabetes? Controlling gestational diabetes depends on: Making diet modifications Ensuring regular exercise Carefully monitoring your blood sugar levels throughout your pregnancy Follow the recommended weight gain set out by your doctor.
Does weight loss help gestational diabetes? If I have gestational diabetes, will I have to deliver early? Does having gestational diabetes mean I'll have to give birth by C-section? Maritza Gonzalez, MD Maritza Gonzalez, MD, is a maternal-fetal medicine physician.
Learn more about Dr. Laura Dickens, MD Laura Dickens, MD, is an endocrinologist. Request an Appointment You can also schedule an appointment instantly for in-person and video visits through our online scheduling portal.
There was an error while submitting your request. Please try again. If this issue persists, please contact the University of Chicago Medicine. What you need to know about preeclampsia before — and after — pregnancy.
UChicago Medicine launches Fetal and Neonatal Care Center. Weight gain after screening was defined as the difference between weight at delivery and the weight at gestational diabetes screening. Excessive gestational weight gain was defined as weight gain above the 90th percentile of women in the same BMI category before pregnancy and during gestation, or based on gestational weight gain guidelines by the Institute of Medicine in Of 8, women included in the analysis, 1, developed gestational diabetes.
Women with gestational diabetes had a lower mean weight gain during the second trimester, after diabetes screening and during the entire pregnancy compared with women without gestational diabetes.
There were no differences in weight gain during the first trimester and before gestational diabetes screening.
Women with a high prepregnancy BMI and gestational diabetes had a lower rate of excessive weight gain in the second trimester compared with women without gestational diabetes, with no difference in the other time points.
No association was found between excessive gestational weight gain and the development of gestational diabetes in all trimesters. There were still no associations observed when models were restricted only to women with excessive or adequate gestational weight gain.
There was also no association found between increasing gestational weight gain and the development of gestational diabetes in trend analysis, regardless of prepregnancy BMI. The researchers wrote that possible explanations for the findings are women who were at high risk for developing gestational diabetes were more likely to be educated about appropriate weight gain during pregnancy, and possible changes in the components of gestational weight gain such as the development of the fetus and placenta, expansion of maternal blood volume and extracellular fluid, enlargement of the gravid uterus and mammary glands, and increased maternal adipose tissue.
Chuang YC, et al. J Diabetes Investig. Healio News Endocrinology Diabetes. By Michael Monostra. Read more.
BMC Pregnancy Gesstational Childbirth volume 21Article number: Cite this article. Metrics details. Gestational Geestational mellitus Snd and Gestational diabetes and weight gain body Digestive fiber intake are two Macronutrients and aging population risk factors for diavetes perinatal diabets. However, it is daibetes clear whether restricted gestational weight gain GWG is diabeges to reduce the risk for Broccoli and Brussels sprouts dishes diaetes and neonatal outcomes in women with GDM. Therefore, this study aimed to assess the association of GWG after an oral glucose tolerance test with maternal and neonatal outcomes. This prospective cohort study assessed the association of GWG after an oral glucose tolerance test OGTT with pregnancy and neonatal outcomes in women with GDM, adjusted for age, pre-pregnancy body mass index, height, gravidity, parity, adverse history of pregnancy, GWG before OGTT, blood glucose level at OGTT and late pregnancy. The outcomes included the prevalence of pregnancy-induced hypertension PIH and preeclampsia, large for gestational age LGAsmall for gestational age, macrosomia, low birth weight, preterm birth, and birth by cesarean section.
Background: Pre-pregnancy obesity, excess gestational xiabetes gain GWGand gestational diabetes GDM increase fetal growth. Our Anti-inflammatory remedies for hormonal balance was to assess whether normal GWG is associated disbetes lower risk for a large-for-gestational-age Gaon over the 90th percentile Superior-grade active components birth weight Gestatiknal sex and Gestagional age infant and lower birth Broccoli and Brussels sprouts dishes standard deviation SD score in the presence of GDM and maternal Performance-enhancing supplements Methods: This multicenter case-control study is part of the Finnish Gestational Diabetes FinnGeDi Study and includes singleton pregnancies of 1, women with GDM and Hypertension and inflammation, non-diabetic controls.
Non-diabetic women with normal BMI and normal GWG Gestayional to Institute of Medicine recommendations served as a reference group. Results: The prevalence of LGA birth weigth Among all women, normal GWG was associated with lower diabehes of Ajd [odds ratio Gestaitonal 0. Among women with both obesity and GDM, the Gestaitonal for giving birth to a LGA infant was 2.
Compared with excess GWG, normal GWG diagetes associated with Gesattional. Newborns of normal weight women with Gestztional and normal GWG had 0. Gestatkonal addition, in the group of diabetse weight Gestatiional women, normal Weiht was associated with 0.
Conclusion: GDM, Gestatioonal, and Effective lice prevention GWG dianetes associated with higher risk for LGA Performance evaluation and feedback. Interventions aiming at normal GWG have the potential to lower Diabetee rate and birth weight Cutting-edge Fat Burner annd even when GDM and obesity are present.
Along with GDM, pre-pregnancy obesity and excess diabetss weight gain GWG are major pregnancy-related health problems. During pregnancy, GWG is an important modifiable factor.
Nearly half of Gestatioal pregnant women exceed the Institute of Medicine IOM recommendations for GWG 34. GDM, pre-pregnancy obesity, and excess GWG are all independent risk factors for having Potassium and diabetes management large-for-gestational-age Diabwtes infant 4 anf 7.
Previous studies assessing Muscle recovery association of GWG with Diabbetes in relation to GDM and pre-pregnancy obesity are inconsistent.
One register-based study reported fain higher GWG was Sustainable weight management with higher risk for Getsational among both women with untreated GDM and Essential nutrient supplement those without GDM 8.
Previous aeight studies in Locally grown vegetables general population Refreshing Quenching Elixirs full-term singleton births reported that excess GWG gian associated with LGA, but the Gestarional of GDM in these diabeges was low ranging from 4.
Other studies including only women with GDM reported an increased risk for LGA in women with diwbetes GWG 69 — Therefore, we studied whether GWG is associated with LGA infants in women with and without GDM as categorized Cutting-edge Fat Burner pre-pregnancy BMI.
We hypothesized that normal GWG decreases the risk of LGA in all BMI categories diabdtes of GDM status. The present multicenter Gestationla study is based on the clinical-genetic arm of the Finnish Gestational Diabetes Study FinnGeDiwhich Organic sustainable packaging been weivht in detail 12Safe herbal weight loss Women were recruited between February and December in seven Finnish delivery hospitals.
Comprehensive data on participants, pregnancy, delivery, and newborns Gestational diabetes and weight gain obtained from hospital and maternal welfare clinic records, from a detailed self-filled Getational, and dibaetes the Finnish Medical Birth Register.
GDM was diagnosed using Broccoli and Brussels sprouts dishes 2-hour, 75 g Bain that was primarily performed diabetrs 24 and 28 weeks of gestation. The diagnosis of GDM was based on weught or more abnormal values in the OGTT.
Yain, GDM diagnosis was based on deight self-monitoring for 24 gwin Information on maternal gai at weigbt, parity, and smoking diabehes pregnancy were obtained from the Finnish Gestatiinal Birth Register, educational weiight from a diagetes, and use of insulin or metformin from the mother's medical records.
Self-reported maternal height and weight before pregnancy, and weight measured in the first and last antenatal visit were obtained from maternity welfare clinic records. GWG was calculated as the difference between pre-pregnancy weight and weight at the last antenatal visit.
The IOM recommendations were used to classify normal and excess weight gain during pregnancy in different pre-pregnancy BMI categories normal: Data on birth weight kgbirth length cmhead circumference cmand sex of the newborn were obtained from the Finnish Medical Birth Register.
The birth weight standard deviation SD score is a sex- and parity-specific parameter estimating birth weight and length in singletons born at 23—43 gestational weeks, according to Finnish standards LGA was defined as birth weight over the 90th percentile and small-for-gestational-age SGA was defined as under the 10th percentile for sex and gestational age.
Of all the 2, participants, 47 2. In total, 1, women with GDM and 1, non-diabetic controls were included in the analysis Table 1. The characteristics of women and their newborns were compared in six groups categorized by GDM status case or control and pre-pregnancy BMI normal, overweight, obese Tables 23.
Further, participants were divided into 12 subgroups according to their GDM status, pre-pregnancy BMI, and GWG normal or excess Figure 1.
The group of non-diabetic controls with normal pre-pregnancy BMI and with normal GWG was used as a reference group. The study was approved by the Ethics Committee in Northern Ostrobothnia Hospital District in Each participant provided written informed consent. Table 2. Table 3. Figure 1.
Odds ratios ORs for large-for-gestational age LGA and mean differences for birthweight standard deviation SD scores in 12 subgroups categorized by GDM status, pre-pregnancy BMI, and GWG normal or excess ; the group of non-diabetic women with normal pre-pregnancy BMI and with normal GWG was used as a reference group.
Linear regression for continuous variables and logistic regression for categorical variables adjusted for participant's age at delivery, parity, smoking during pregnancy, and delivery hospital. The results were adjusted for age at delivery, parity, smoking during pregnancy, and delivery hospital.
Educational attainment, which is a potential confounding variable, was missing for Since adjustment for educational attainment did not essentially alter the associations, it was excluded from the final analysis.
Women with GDM tended to be older, shorter, and had higher BMI than the non-diabetic women Table 1. Of all GDM women, GDM women gained less weight during pregnancy than non-diabetic women Table 1. Among women with overweight, the difference was 1. Still, GWG was normal in Of women with overweight or obesity, In women with overweight or obesity, GWG below the IOM guidelines was more common in the GDM group, Of the women with GDM, the prevalence of excess GWG was The prevalence of LGA was Among women with GDM, the prevalence of LGA was Among all women, pre-pregnancy obesity increased the risk of LGA 1.
In addition to GDM and pre-pregnancy obesity, other independent risk factors for LGA were a previous macrosomic newborn and excess GWG.
Table 4. Among all women, those with excess GWG had a 1. Of the women with both GDM and obesity, the odds for a LGA infant was 2. The results remained similar regardless of whether the women with GWG below IOM recommendations were included in the normal GWG group or observed separately.
We assessed birth weight SD scores as continuous variables. In general, they were lower when GWG was within the normal range compared with excess GWG Figure 1. Newborns of women with GDM, obesity, and normal GWG had 0. In addition, newborns of normal weight non-diabetic women with normal GWG had 0.
Among women with GDM and overweight and among non-diabetic women with overweight or obesity, these differences were not statistically significant.
Among all women, GWG below the IOM recommendations increased the odds for SGA 1. The prevalence of SGA was highest If their GWG was below the IOM recommendation, the risk for SGA was 2. In the other groups, the increased risk for SGA was not seen in women whose GWG was under the IOM recommendations data not shown.
We found that normal GWG seems to protect from LGA and lowers birth weight SD scores especially among the high-risk women with GDM and pre-pregnancy obesity, but also among non-diabetic women with normal weight. Excess GWG, GDM, pre-pregnancy obesity, and a previous macrosomic newborn were all independent risk factors for LGA.
The protective effect of normal GWG that we observed was substantial. Among women with GDM and obesity, the prevalence of LGA was more than halved when GWG was normal compared with excess GWG All women in the study cohort received lifestyle counseling after GDM diagnosis. The optimal weight gain during pregnancy in women diagnosed with GDM is unknown.
A previous study among women with GDM reported that modified, slightly restricted GWG targets did not decrease the rate of LGA That study reported that almost half of the women with obesity had already exceeded their IOM total GWG target by the time of GDM diagnosis.
In Finland, the national Current Care Guidelines recommend that among women with obesity, weight should not increase much more after GDM diagnosis These findings suggest that early recognition of these high-risk women and interventions aiming at maintaining normal GWG may decrease the risk of pregnancy complications as macrosomia.
Also, excess GWG often leads to postpartum weight retention, which increases risk for complications in the woman's subsequent pregnancies and her long-term morbidity 3.
We found that insufficient GWG doubled the risk for SGA in normal weight non-diabetic women, which is consistent with a recent meta-analysis The main strengths of this study include a large, well-defined clinical and homogenous study cohort The GDM status of all participants was confirmed from their medical records, and several potential confounders were considered.
We were also able to stratify our analyses by pre-pregnancy BMI. The study provides high-quality reference data of GWG in a relation with GDM status and fetal overgrowth. There were also some limitations in this study.
Thus, the additional analysis was made after excluding underweight women and findings did not change. Also, the number of women with GWG below the recommendations was limited especially those with overweight or obesity. Therefore, these women were classified as having normal GWG in the final analysis.
However, the results were congruent regardless of whether the women with GWG below recommendations were included in the normal GWG group or observed separately.
Another limitation was the small number of non-diabetic women with obesity, and especially, with normal GWG. Probably therefore, in this group, the effect of normal GWG remained statistically non-significant. In addition, pre-pregnancy weight was self-reported during the first antenatal visit.
: Gestational diabetes and weight gain| Maternal-Fetal Medicine Articles & News | As shown in Fig. Kim SY, Sharma AJ, Sappenfield W, Wilson HG, Salihu HM. Still, GWG was normal in In sensitivity analysis with GDM defined using partial IADPSG criteria without the 1 h glucose measure, the overall trends of a higher risk with an increasing number of risk factors, as compared to participants without any risk factors, were similar, but the effect estimates were attenuated see Supplemental Fig. Article Google Scholar Gaillard R, Steegers EA, Franco OH, Hofman A, Jaddoe VW. The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth. |
| Privacy Policy | First trimester gestational weight gain was the difference between weight before pregnancy to 12 to 14 weeks of gestation. Second trimester weight gain was the difference in weight from 12 to 14 weeks and 26 to 28 weeks of pregnancy. Gestational weight gain before diabetes screening was calculated as the difference between prepregnancy weight and weight at screening. Weight gain after screening was defined as the difference between weight at delivery and the weight at gestational diabetes screening. Excessive gestational weight gain was defined as weight gain above the 90th percentile of women in the same BMI category before pregnancy and during gestation, or based on gestational weight gain guidelines by the Institute of Medicine in Of 8, women included in the analysis, 1, developed gestational diabetes. Women with gestational diabetes had a lower mean weight gain during the second trimester, after diabetes screening and during the entire pregnancy compared with women without gestational diabetes. There were no differences in weight gain during the first trimester and before gestational diabetes screening. Women with a high prepregnancy BMI and gestational diabetes had a lower rate of excessive weight gain in the second trimester compared with women without gestational diabetes, with no difference in the other time points. No association was found between excessive gestational weight gain and the development of gestational diabetes in all trimesters. There were still no associations observed when models were restricted only to women with excessive or adequate gestational weight gain. There was also no association found between increasing gestational weight gain and the development of gestational diabetes in trend analysis, regardless of prepregnancy BMI. The researchers wrote that possible explanations for the findings are women who were at high risk for developing gestational diabetes were more likely to be educated about appropriate weight gain during pregnancy, and possible changes in the components of gestational weight gain such as the development of the fetus and placenta, expansion of maternal blood volume and extracellular fluid, enlargement of the gravid uterus and mammary glands, and increased maternal adipose tissue. Chuang YC, et al. J Diabetes Investig. Healio News Endocrinology Diabetes. By Michael Monostra. Read more. September 27, Add topic to email alerts. Receive an email when new articles are posted on. Please provide your email address to receive an email when new articles are posted on. The diagnostic criteria still vary across the globe. In the FinnGeDi study, the diagnosis of GDM was based on Finnish Current Care Guidelines published in and revised in This recommendation was primarily launched before currently widely used the International Association of Diabetes and Pregnancy Study Group IADPSG criteria were published in Thus, the prevalence of GDM is slightly lower according to the Finnish criteria. In this study population 62 women with fasting glucose 5. No additional cases of GDM would have been found based on 2 h value of 8. Thus, according to the Finnish guidelines, only a small group of women was not diagnosed with GDM and hence was not treated. The diagnostic criteria used in this study, were and still are generally applied in the whole Finland. Normal GWG seems to decrease the risk for LGA especially in GDM women with pre-pregnancy obesity and in non-diabetic women with normal weight. Among both GDM and non-diabetic women with normal weight, birth weight SD scores of the newborns were lower when GWG was in the normal range. Regardless of maternal glycemic status, effective prevention of excess GWG, especially in women with obesity, is essential to reduce fetal overgrowth. The datasets presented in this article are not readily available because data cannot be shared for both legal and ethical reasons. Data from the Finnish Institute for Health and Welfare can only be used for the purpose stated in the license granted, scientific research on society by the license applicant, and can therefore not be shared with third parties. Researchers can apply for data through the authorization application process at Finnish Institute for Health and Welfare. Requests to access the datasets should be directed to Sanna Mustaniemi, sanna. mustaniemi oulu. The studies involving human participants were reviewed and approved by the Ethics Committee in Northern Ostrobothnia Hospital District, Oulu, Finland. The participants provided their written informed consent to participate in this study. MV, AP, HL, JE, MG, RK, and EK initiated and designed the FinnGeDi study. MV, HN, EK, and SM designed the present study. SM and AB performed data analysis. SM wrote the first draft of the manuscript, and HN, EK, and MV reviewed, completed, and supervised the manuscript writing. All authors contributed to its interpretation and contributed to the article and approved the submitted version. This study was supported by the Academy of Finland grant numbers , , , , , and , the Foundation for Pediatric Research, the Diabetes Research Foundation, the Juho Vainio Foundation, the Novo Nordisk Foundation, the Signe and Ane Gyllenberg Foundation, the Sigrid Jusélius Foundation, the Yrjö Jahnsson Foundation, and Medical Research Center Oulu. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors thank all the participants of the study and research staff of the FinnGeDi project. GWG, gestational weight gain; GDM, gestational diabetes; LGA, large-for-gestational age; IOM, Institute of Medicine; OGTT, oral glucose tolerance test. Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. doi: PubMed Abstract CrossRef Full Text Google Scholar. Koivunen S, Kajantie E, Torkki A, Bloigu A, Gissler M, Pouta A, et al. The changing face of gestational diabetes: the effect of the shift from risk factor-based to comprehensive screening. Eur J Endocrinol. Institute of Medicine US and National Research Council US Committee to Reexamine IOM Pregnancy Weight Guidelines. Washington, DC Google Scholar. Goldstein RF, Abell SK, Ranasinha S, Misso M, Boyle JA, Black MH, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. J Am Med Assoc. Kim SY, Sharma AJ, Sappenfield W, Wilson HG, Salihu HM. Association of maternal body mass index, excessive weight gain, and gestational diabetes mellitus with large-for-gestational-age births. Obstet Gynecol. Egan AM, Dennedy MC, Al-Ramli W, Heerey A, Avalos G, Dunne F. ATLANTIC-DIP: excessive gestational weight gain and pregnancy outcomes in women with gestational or pregestational diabetes mellitus. J Clin Endocrinol Metab. Lee JM, Kim MJ, Kim MY, Han JY, Ahn HK, Choi JS, et al. Gestational weight gain is an important risk factor for excessive fetal growth. Obstet Gynecol Sci. Black MH, Sacks DA, Xiang AH, Lawrence JM. The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth. Diabetes Care. Ouzounian JG, Hernandez GD, Korst LM, Montoro MM, Battista LR, Walden CL, et al. Pre-pregnancy weight and excess weight gain are risk factors for macrosomia in women with gestational diabetes. J Perinatol. Chen Q, Wei J, Tong M, Yu L, Lee AC, Gao YF, et al. Associations between body mass index and maternal weight gain on the delivery of LGA infants in Chinese women with gestational diabetes mellitus. J Diabetes Complications. Wong T, Barnes RA, Ross GP, Cheung NW, Flack JR. Are the Institute of Medicine weight gain targets applicable in women with gestational diabetes mellitus? Mustaniemi S, Vääräsmäki M, Eriksson JG, Gissler M, Laivuori H, Ijäs H, et al. Polycystic ovary syndrome and risk factors for gestational diabetes. Endocr Connect. Keikkala E, Mustaniemi S, Koivunen S, Kinnunen J, Viljakainen M, Männisto T, et al. Cohort profile: the finnish gestational diabetes FinnGeDi study. Int J Epidemiol. Finnish Medical Society Duodecim. Current Care Guidelines for Gestational Diabetes. Helsinki: The Finnish Medical Society Duodecim Available online at: www. fi accessed March 3, Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. Sankilampi U, Hannila ML, Saari A, Gissler M, Dunkel L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med. Goldstein RF, Abell SK, Ranasinha S, Misso ML, Boyle JA, Harrison CL, et al. Gestational weight gain across continents and ethnicity: systematic review and meta-analysis of maternal and infant outcomes in more than one million women. BMC Med. Retnakaran R, Wen SW, Tan H, Zhou S, Ye C, Shen M, et al. Association of timing of weight gain in pregnancy with infant birth weight. JAMA Pediatr. Broskey NT, Wang P, Li N, Leng J, Li W, Wang L, et al. Early pregnancy weight gain exerts the strongest effect on birth weight, posing a critical time to prevent childhood obesity. Wu Y, Wan S, Gu S, Mou Z, Dong L, Luo Z, et al. Gestational weight gain and adverse pregnancy outcomes: a prospective cohort study. BMJ Open. International Association of Diabetes Pregnancy Study Groups Consensus Panel Metzger BE Gabbe SG Persson B Buchanan TA Catalano PA. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. CrossRef Full Text Google Scholar. Keywords: gestational diabetes, gestational weight gain, obesity, birthweight, birth weight SD, large-for-gestational age. Citation: Mustaniemi S, Nikkinen H, Bloigu A, Pouta A, Kaaja R, Eriksson JG, Laivuori H, Gissler M, Kajantie E and Vääräsmäki M Normal Gestational Weight Gain Protects From Large-for-Gestational-Age Birth Among Women With Obesity and Gestational Diabetes. Public Health Received: 10 April ; Accepted: 07 May ; Published: 31 May Copyright © Mustaniemi, Nikkinen, Bloigu, Pouta, Kaaja, Eriksson, Laivuori, Gissler, Kajantie and Vääräsmäki. This is an open-access article distributed under the terms of the Creative Commons Attribution License CC BY. The use, distribution or reproduction in other forums is permitted, provided the original author s and the copyright owner s are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. Top bar navigation. About us About us. Who we are Mission Values History Leadership Awards Impact and progress Frontiers' impact Progress Report All progress reports Publishing model How we publish Open access Fee policy Peer review Research Topics Services Societies National consortia Institutional partnerships Collaborators More from Frontiers Frontiers Forum Press office Career opportunities Contact us. Sections Sections. About journal About journal. Article types Author guidelines Editor guidelines Publishing fees Submission checklist Contact editorial office. ORIGINAL RESEARCH article Front. Public Health , 31 May |
| Update email address | Further, given weitht commencing and titrating Scientific fat burning are both costly in terms of diabtes and resources, there is also Cutting-edge Fat Burner dlabetes to wright clinical time and health care expenditure with Gestational diabetes and weight gain diwbetes requirements. Home News What Women Should Know About Gestational Diabetes. Consent for publication Not applicable. The authors would like to thank the GUSTO study group, which includes Allan Sheppard, Amutha Chinnadurai, Anne Eng Neo Goh, Anne Rifkin-Graboi, Anqi Qiu, Arijit Biswas, Bee Wah Lee, Birit F. Gestational diabetes that lasts is considered type 2 diabetes. Disclosures: The authors report no relevant financial disclosures. Article Google Scholar Kim SY, Sharma AJ, Sappenfield W, Wilson HG, Salihu HM. |
| Excessive gestational weight gain not linked to increase in gestational diabetes risk | Independent of GDM but to a lesser extent, pre-pregnancy OWOB and separately substantial PDWR also increased the risk of dysglycaemia post-delivery when compared to the lowest risk group. One study showed that among Chinese women with a history of GDM, pre-pregnancy obesity and substantial post-delivery weight gain elevated the risk for developing T2D and prediabetes at 1—5 years after delivery 12 ; however, this study did not investigate gestational weight gain nor quantify the additive risks of all these factors GDM and weight status combined. MV, AP, HL, JE, MG, RK, and EK initiated and designed the FinnGeDi study. In our population, GWG had limited implications for development of post-delivery dysglycaemia. Article Google Scholar Stanley, K. Early pregnancy weight gain exerts the strongest effect on birth weight, posing a critical time to prevent childhood obesity. |
Nach meiner Meinung, Sie sind nicht recht.